プライマリーケアにおけるベンゾジアゼピン不適切な処方の廃止: 行動フレームワークによる体系的なレビューの概要
Giuliano Duarte-Anselmi1, Modesta Pousada Fernández2, Beni Gómez-Zúñiga2
1Facultad de Ciencias Médicas, Universidad de Santiago de Chile, Av. Libertador Bernardo O'Higgins 3363, Estación Central, Santiago, Chile. giuliano.duarte@usach.cl.
Implementation science communications
|February 20, 2026
まとめ
患者教育と薬剤師の関与を含む多面的な介入は,初等医療における不適切なベンゾジアゼピン (BZD) 処方量を効果的に削減します. 理論に基づいたアプローチは,より安全なBZDの解読のために,介入の設計と持続可能性を高めます.
科学分野:
- 薬理学とセラピュティクス
- プライマリーケア医療 プライマリーケア医療
- 行動科学は,行動科学である.
背景:
- ベンゾジアゼピン (BZD) の長期使用は,認知機能障害,転倒,依存症を含む重大な健康リスクをもたらす.
- 現在のガイドラインは,長期間使用するBZDを推奨していないが,初等医療における効果的な抑うつ薬の処方戦略に関する証拠は断片化されている.
- 不適切なBZDの処方に関する問題に対処することは,患者の安全と効果的な医療管理にとって極めて重要です.
研究 の 目的:
- プライマリケアにおける不適切なBZD処方量を減らすための介入に関する体系的なレビューからの証拠を統合する.
- BZDの解読に影響を与える障壁や促進者を特定する.
- 介入の効果を評価し,行動理論の役割を評価する.
主な方法:
- 2024年9月15日までの4つの主要なデータベースにおける体系的なレビューの包括的な文献検索.
- 初等医療従事者を対象としたうつ病診断戦略を評価するシステマティック・レビューの導入.
- AMSTAR-2を使用して,介入の特徴,行動変化のテクニック,アウトカム,方法論的な品質評価に関するデータ抽出.
主要な成果:
- 279件のプライマリ研究を含む14件のシステマティックレビューが含まれた.
- 共通の戦略には,漸進的な投与量削減 (71%),患者教育 (50%),薬剤師主導の介入 (36%) が含まれていた.
- 患者教育と薬剤師の関与を統合した多面的な介入は,より高い持続的効果を示した;行動理論を使用した研究はほとんどありませんでした.
結論:
- 多面的な介入,特に患者教育,監査とフィードバック,および薬剤師の関与を含む介入は,不適切なBZDの使用を減らすのに最も効果的です.
- 理論に基づいた介入は,たとえ短期間であっても,適度に効果的であり,明確な理論的枠組みの必要性を強調します.
- 将来の研究は,患者中心の戦略,長期の遵守,およびBZDの処方停止のための多様な社会経済的環境を優先すべきである.
さらに関連する動画
関連する概念動画
CNS Depressants: Barbiturates and Benzodiazepines
1.5K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.5K
Sedatives and Hypnotics Drugs: Benzodiazepines
1.0K
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
1.0K
Anxiolytic Drugs: Benzodiazepines and Buspirone
2.7K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.7K
Anxiolytic Drugs: Overview
1.3K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.3K
Sedatives and Hypnotics: Overview
1.7K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.7K
Sedatives and Hypnotics Drugs: Barbiturates
1.2K
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
1.2K


